| |
|
Yahoo! News: Health News Fri, 03 Sep 2010 03:48:25 GMT |
-
Can home cooking be hazardous to your health?
(AP)
- AP - Could your kitchen at home pass a restaurant inspection?
-
Botox maker to pay $600M to resolve investigation
(AP)
-
AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
-
New test seen as big advance in diagnosing TB
(AP)
-
AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.
-
Journal editors question sale of diet pill Meridia
(AP)
- AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.
-
Benefits seen for high-risk women in ovary removal
(AP)
- AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.
-
Double hand transplant patient shows new hands
(AP)
-
AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.
-
Study: Diet Drug Meridia May Boost Heart Risks
(Time.com)
- Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke
-
For Bonobo Males, Mom Is the Best Wingman
(LiveScience.com)
- LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.
-
Clinical Trials Update: Sept. 2, 2010
(HealthDay)
- HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
-
Timer may help kids' bladder control problems
(Reuters)
- Reuters - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.
-
Seniors Get Boost From Bad News About the Young
(HealthDay)
- HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- Older people prefer to read
negative news stories about the young, possibly because it makes them feel
better about themselves, a new study suggests.
-
Bone drugs may raise risk of throat cancer
(AP)
- AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.
-
Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in
Mice
(HealthDay)
- HealthDay - WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to
treat high blood sugar in type 2 diabetics may hold some promise in the
prevention of tobacco-induced lung cancer, according to extremely
preliminary findings in a mouse study.
-
Safety groups find no Pampers link to rash cases
(Reuters)
- Reuters - Two agencies investigating claims that Procter & Gamble Co's Pampers Dry Max gave children severe diaper rash reported Thursday that they have found no specific cause linking the diapers to rashes.
-
HIV discrimination case filed in China
(AP)
- AP - A municipal court in central China has accepted the country's first lawsuit alleging work discrimination because of HIV status, state media reported Tuesday.
-
Diabetes drug may keep lung cancer at bay
(Reuters)
-
Reuters - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.
-
Health Tip: Coping With Hives
(HealthDay)
- HealthDay - (HealthDay News) -- Hives are the result of an allergic reaction.
They typically go away without treatment, but can be an itchy
nuisance.
-
Abbott diet drug study renews calls for U.S. ban
(Reuters)
- Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
|
|
|